Endo Announces $200 Million Settlement for TRT Lawsuits
Endo Announces $200 Million Settlement for TRT Lawsuits

Introduction
Endo International announced a $200 million settlement, thus resolving 1,300 Testosterone product liability cases. The company stated this "master settlement agreement" will conclude "all known" cases and the deal does not include any admission of wrongdoing. The plaintiffs are required to release their claims from a settlement fund where the amount will be deposited by the company.
About 900 testosterone lawsuits are federally-filed against Endo and several other drugmakers for hiding potential risks of TRT. Additional lawsuits are also filed in the Philadelphia Court of Common Pleas and in state courts.
Testosterone Replacement therapy lawsuits were consolidated as a multidistrict litigation (MDL No. 2545 ) in June 2014 before U.S. District Judge Matthew Kennelly in the U.S. District Court for the Northern District of Illinois. All the lawsuits claim similar allegations that the drugmakers falsely marketed the TRT drug and failed to provide adequate warnings to the consumers.
Latest News
Oregon to Get $66M in Sackler Opioid Settlement
Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…